Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial,”1 published online May 29, 2020, there was a change made to the license type from standard to open access. This article was corrected online.
Change to Licensing Type. JAMA Oncol. 2020;6(9):1473. doi:10.1001/jamaoncol.2020.2873
Coronavirus Resource Center